Non-Invasive Brain Imaging Techniques That Predict Antidepressant Responsiveness and Provide Insights Into the Mechanism of Action of Venlafaxine ER vs. Fluoxetine
Phase of Trial: Phase II
Latest Information Update: 29 Dec 2014
At a glance
- Drugs Venlafaxine (Primary) ; Fluoxetine
- Indications Major depressive disorder
- Focus Biomarker; Therapeutic Use
- 29 Dec 2014 Last checked against ClinicalTrials.gov record.
- 07 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jun 2009 New trial record